John Savage

John Savage has worked in a variety of scientific roles since 2007. Starting as a Postdoctoral Fellow at Cornell University, they then became a Postdoctoral Researcher at UNC Lineberger Comprehensive Cancer Center. In 2011, they joined Liquidia Technologies as a Scientist and then moved to Envisia Therapeutics in 2013 as a Senior Scientist. In 2014, they returned to Liquidia Technologies as a Principal Scientist and in 2019 joined Lindy Biosciences, Inc. as both a Director of R&D and a Principal Scientist.

John Savage attended the University of Massachusetts Amherst from 2001 to 2007, where they earned a Doctoral degree in Physics.